Fas ligand as a tool for immunosuppression and generation of immune tolerance.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15536183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of Fas ligand (FasL) in physiologically limiting immune responses and maintaining immune-privileged sites has led to a body of research aiming to confer protection to allogeneic grafts by expressing FasL on the allogeneic tissue or by administrating FasL-transduced donor dendritic cells. In addition, several studies have used FasL to abrogate autoimmune responses. This review presents the results of these studies and discusses the problems associated with FasL usage.
Medical subject headings
- Immunosuppressive Agents
- Membrane Glycoproteins
- Transplantation